Kerala Ayurveda informs about press release

19 Jul 2025 Evaluate

Kerala Ayurveda has informed that KAL reports 44% revenue growth in Q1 26 vs. PY (38% growth excluding Ayurvedagram Bali). Adjusted EBITDA* positive at Rs.6.4 Crs (+Rs.5.4 Crs. vs. PY) with continued investment in talent hiring, marketing and building infrastructure over the first quarter of 2026. KAL continues on its path to Double the growth rate in 2026 to 50% topline growth with investments in chosen drivers of growth - the Digital and Health service businesses powered by world class talent, marketing, technology and international expansion. Press release regarding the same enclosed.

The above information is a part of company’s filings submitted to BSE.

Kerala Ayurveda Share Price

341.90 -5.15 (-1.48%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×